Rankings
▼
Calendar
NUVL Q4 2020 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena
NUVL
Nuvalent, Inc.
$8B
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$5M
Net Income
-$7M
EPS (Diluted)
$-0.29
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$42,000
Balance Sheet
Total Assets
$11M
Total Liabilities
$42M
Stockholders' Equity
-$31M
Cash & Equivalents
$10M
← FY 2020
All Quarters
Q1 2021 →
